Soquelitinib Data in T-Cell Lymphoma: Promising Results Unveiled
Corvus Pharmaceuticals released additional data from its Phase 1/1b clinical trial of soquelitinib, an oral ITK inhibitor, for T-cell...
Pathos AI Doses First Patient in Pocenbrodib Trial
Pathos AI has initiated a Phase 1b/2a clinical trial for its CBP/p300 inhibitor, pocenbrodib, in patients with metastatic castration-resistant...
Milestone Pharmaceuticals to Present Etripamil Data at ACC
Milestone Pharmaceuticals announced a poster presentation at the American College of Cardiology annual meeting (ACC25) from March 29th-31st, 2025,...
Celz-201-DDT FDA Clearance for Chronic Lower Back Pain Trial
Creative Medical Technology Holdings (CELZ) announced positive interim data from its Phase 1/2 trial of StemSpine using AlloStem (CELZ-201-DDT),...
WuGen Announces Dosing in Wu-CART-007 Trial
Wugen, Inc. has begun its pivotal Phase 2 trial of WU-CART-007, an off-the-shelf CAR-T cell therapy for relapsed or...
Genenta Secures €20M, Brain Tumor Trial Shows Promising Survival
Genenta Science secured €20 million (approximately $21.9 million) in financing from ENEA Tech and Biomedical (ETB) to support the...
Pharming Group Announces First Patient Dosed in Phase II Trial for CVID
Pharming Group N.V. has initiated a Phase II clinical trial for leniolisib, targeting common variable immunodeficiency (CVID) patients with...
Savolitinib Shines in HutchMed Phase II Lung Cancer Trial
HUTCHMED announced new data from studies of savolitinib and surufatinib, two compounds it discovered, will be presented at the...
First-of-its-kind Study Shows Monopoint System Utility in IIH Treatment
Route 92 Medical announced positive multicenter study results for their Monopoint system, a novel catheter technology designed for neurovascular...
Tenaya Therapeutics Unveils Breakthrough Cardiac Data at ACC Conference
Tenaya Therapeutics will present new clinical data from the MyPEAK-1 Phase 1b/2 trial of TN-201, a gene therapy for...